MATE Act: Substance Use Disorder - Assessment, Addiction Treatment and Mood Disorders
Federal and state policy over the last decade has sought to overcome the long-term effects of substance misuse impacting individuals, families, communities, and those charged with resource allocation. The recently passed Medication Access and Training Expansion (MATE) Act, requires new or renewing DEA registrants to have completed a total of at least 8 hours of training in opioid or other substance use disorders.
This course is compliant with the MATE Act and will address substance use disorders and effective treatment planning.
FAQ MATE Act (click here)
Topics within this module include:
• Introduction to substance use disorders
• Assessment and treatment of mood and substance use disorders in the primary care setting
• Addiction treatment in the primary care setting
Target Audience
Drug Enforcement Administration (DEA) registered practitioners.
Learning Objectives
- Describe the clinical impact of screening, brief intervention and referral to treatment (SBIRT) and motivational interviewing in the healthcare setting.
- Examine the clinical application of validated screening tools.
- Describe the limitations of urine drug testing.
- Assess, treat, and manage substance use disorders.
- Identify the importance of substance use disorder management in mood disorders.
- Discuss the neurobiology, diagnosis and treatment of addiction.
Michelle Krichbaum, Pharm.D., BCPP
Clinical Manager, Pain Management and Palliative Care
Baptist Health South Florida
Miami, Florida
Neil Miransky, D.O.
Chief Medical Officer, Pharmacy
Baptist Health South Florida
Miami, Florida
Rachel Rohaidy, M.D.
Interventional Psychiatrist
Co-director, Transcranial Magnetic Stimulation
Board Certified in Adult and Addiction Psychiatry
Miami Neuroscience Institute
Baptist Health South Florida
Miami, Florida
Rachel Rohaidy, M.D., Michelle Krichbaum, Pharm.D., BCPP, and Neil Miransky, D.O., faculty for this educational activity, have no relevant financial relationships with ineligible companies* to disclose, and have indicated that the presentations or discussions will not include off-label or unapproved product usage.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies ― Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 2.00 General certificate of attendance
- 2.00 Florida Board of Dentistry
- 2.00 Florida Board of Podiatric Medicine
Price
Required Hardware/Software
PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| |||||||
Mobile UsersThis site is supported on the following mobile devices:
| |||||||
Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |